Immunomedics Inc. (NASDAQ:IMMU) Archives - BioPharmaJournal

Home Tags Immunomedics Inc. (NASDAQ:IMMU)

Immunomedics Inc. (NASDAQ:IMMU) Reports Encouraging Results from Pivotal Phase 2 TROPHY...

Kate Hudson - September 30, 2020 0

Gilead Sciences Inc. (NASDAQ:GILD) Announce $21 Billion Acquisition Of Cancer Drug...

Ward Sport - September 22, 2020 0

Immunomedics, Inc. (NASDAQ:IMMU) Reports Revenues Of $20.1 Million In Q2 2020:...

Gavins Felicity - August 24, 2020 0

Immunomedics, Inc. (NASDAQ:IMMU) Expands Its Current Clinical Collaboration with Roche to...

Ward Sport - July 27, 2020 0

Immunomedics Inc. (NASDAQ:IMMU) Reports Positive Phase 3 Trodelvy Study Results In...

Ward Sport - July 14, 2020 0

.td-post-views{ display: none !important; }